Low molecular weight heparin as adjuvant therapy in active ulcerative colitis
Low molecular weight heparin as adjuvant therapy in active ulcerative colitis
复制标题
DOI：
10.1046/j.1365-2036.1999.00599.x
复制
发表时间：
1999-10
影响因子：
7.6
通讯作者：
Törkvist;Thorlacius;Sjöqvist;Bohman;Lapidus;Flood;Ågren;Raud;Löfberg
中科院分区：
文献类型：
--
作者：
Törkvist;Thorlacius;Sjöqvist;Bohman;Lapidus;Flood;Ågren;Raud;Löfberg
: Heparin given intravenously has shown beneficial effects in the treatment of refractory ulcerative colitis in open trials. Low molecular weight heparin (LMWH) offers advantages in the method of administration but have not been evaluated in inflammatory bowel disease conditions.
